Efficacy of topical ciprofloxacin 0.3% in the treatment of ulcerative keratitis in humans

Annals of Ophthalmology - Glaucoma

Volumn 30, Issue 5, 1998, Pages 301-304

  Levey, Stephanie B ^b   Katz, Harold R ^a,b,c   Levine, Eric S ^b   Abrams, Donald A ^b,c   Marsh, Marta J ^c  

^a Sinai Hospital of Baltimore ^*  (United States)

^b SINAI HOSPITAL OF BALTIMORE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CIPROFLOXACIN; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CORNEA DISEASE; DRUG EFFICACY; FEMALE; HUMAN; KERATITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; ULCER;

EID: 0031711899     PISSN: 10794794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Baum JL. Initial therapy of suspected microbial corneal ulcers: broad antibiotic therapy based on prevalence of organisms. Surv Ophthalmol. 1979;24:97-105.
2. Chaudhuri PR, Godfrey B. Treatment of bacterial corneal ulcers with concentrated antibiotic eye drops. Trans Ophthalmol Soc UK. 1982;102:11-14.
3. Steinert RF. Current therapy for bacterial keratitis and bacterial conjunctivitis. Am J Ophthalmol. 1991;112:10S-14S.
4. Jones DB. Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears. Surv Ophthalmol. 1979;24:105-116.
5. Jones DB. Early diagnosis and therapy of bacterial corneal ulcers. Int Ophthalmol Clin. 1973;13:1-29.
6. Parks DJ, Abrams DA, Sarfarazi FA, Katz HR. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. Am J Ophthalmol. 1993;115:471-477.
7. Snyder ME, Katz HR. Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol. 1992;114:336-338.
8. Bowe BE, Snyder JW, Eiferman RA. An in vitro study of the potency and stability of fortified ophthalmic antibiotic preparations. Am J Ophthalmol. 1991;111:686-689.
9. Donnenfeld ED, Schrier A, Perry HD, Aulicino T, Gombert ME, Snyder R. Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor. Ophthalmology. 1994;101:902-905.
10. rd ed. Little, Brown and Company. 1994.
11. Borrmann LR, Leopold IH. The potential use of quinolones in future ocular antimicrobial therapy. Am J Ophthalmol. 1988;106: 227-229.
12. Cokingtin CD, Hyndiuk RA. Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections. Am J Ophthalmol. 1991;112:25S-28S.
13. Leibowitz HM. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol. 1991;112:29S-33S.
14. Leibowitz HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol. 1991;112:34S-47S.
15. Cutarelli PE, Lass JH, Lazarus HM, Putman SC, Jacobs MR. Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity. Curr Eye Res. 1991;10:557-563.
16. Wilhelmus KR, Hyndiuk RA, Caldwell DR, Abshire RL, Folkens AT, Godio LB. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. Arch Ophthalmol. 1993;111:1210-1218.
17. O'Brien TP, Sawusch MR, Dick JD, Gottsch JD. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits. Arch Ophthalmol. 1988;106:1444-1446.
18. Reidy JJ, Hobden JA, Hill JM, Forman K, O'Callaghan RJ. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis. Cornea. 1991;10:25-28.
19. Insler MS, Fish LA, Silbernagel J, Hobden JA, O'Callaghan RJ, Hill JM. Successful treatment of methicillin-resistant Staphylococcus aureus keratitis with topical ciprofloxacin. Ophthalmology. 1991;98:1690-1692.
20. Neu HC. Microbiologic aspects of fluoroquinolones. Am J Ophthalmol. 1991;112:15S-24S.